Schizophrenia

NEI Schizophrenia

NEI Schizophrenia GUIDELINES app brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/364190

Contents of this Issue

Navigation

Page 16 of 19

15 Special Circumstances Treatment-resistant Patients Î Assess for adequate dose and treatment adherence Î Consider clozapine • For patients with an inadequate response to 2 antipsychotics (at least one of which is an atypical antipsychotic) • For patients with persistent suicidality Î Augmentation with another antipsychotic, anticonvulsant, or a benzodiazepine Î Electroconvulsive therapy (ECT) Î Cognitive remediation therapy (CRT) Î Cognitive behavior therapy (CBT) Negative Symptoms Î Assess for factors that may contribute to negative symptoms • Treat with antipsychotics if secondary to positive symptoms • Treat with antidepressants if secondary to depression • Treat with anxiolytics if secondary to anxiety • Treat with antiparkinsonian agents or antipsychotic dose reduction if secondary to EPS Î If negative symptoms are primary • Consider treatment with clozapine or other atypical antipsychotics Î Adjunctive treatment for negative symptoms • SSRI, SNRI, or another antipsychotic Relapse Î When taking oral antipsychotic • Switch to a different oral antipsychotic or increase dose of the current antipsychotic • If treatment nonadherence is suspected ▶ Switch to a depot atypical antipsychotic ▶ Switch to a depot conventional antipsychotic • When taking a depot antipsychotic ▶ Switch from depot conventional to depot atypical antipsychotic ▶ Increase dose or frequency of injections ▶ Supplement with oral formulation of the same antipsychotic

Articles in this issue

Archives of this issue

view archives of Schizophrenia - NEI Schizophrenia